A Regeneron drug hit the mark in a pivotal study, reducing errant bone growth for patients with an ultra-rare and ...

Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder affecting soft tissue ...

A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...

Sustained hypoxia affects orthodontic tooth movement (OTM) by altering osteoclast and osteoblast differentiation, report researchers from the Institute of Science Tokyo, Japan. Hypoxic conditions ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adolescents with overweight or impaired glucose ...

Researchers in Germany have uncovered a hidden receptor, GPR133, that plays a vital role in bone strength. By activating it with a new compound called AP503, they boosted bone density in mice and even ...

Uncemented hip replacement surgery uses implants with roughened surfaces designed to allow the patient's bone to grow ...